5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK
- PMID: 20073132
- PMCID: PMC2726607
- DOI: 10.4161/mabs.1.4.8956
5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK
Abstract
The conference, which was organized by Visiongain and held at the BSG Conference Center in London, provided an excellent opportunity for participants to exchange views on the development, production and marketing of therapeutic antibodies, and discuss the current business environment. The conference included numerous interactive panel and group discussions on topics such as isotyping for therapeutic antibodies (panel chair: Nick Pullen, Pfizer), prospects for fully human monoclonal antibodies (chair: Christian Rohlff, Oxford BioTherapeutics), perspectives on antibody manufacturing and development (chair: Bo Kara, Avecia), market impact and post-marketing issues (chair: Keith Rodgers, Bodiam Consulting) and angiogenesis inhibitors (chair: David Blakey, AstraZeneca).
References
-
- Reichert JM. Monoclonal Antibodies as Innovative Therapeutics. Current Pharma Biotechnol. 2008;9:423–430. - PubMed
-
- Nelson AL, Reichert JM. Development trends for therapeutic antibody fragments. Nat Biotechnol. 2009;4:331–337. - PubMed
-
- Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem. 1977;252:3582–3586. - PubMed
-
- Chapman AP. PEGylated antibodies and antibody fragments for improved therapy: A review. Adv Drug Deliv Rev. 2002;54:531–545. - PubMed
-
- Davis JM, Pennington JE, Kubler AM, Conscience JF. A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies. J Immunol Methods. 1982;50:161–171. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous